ORTINGLOBE

Healthcare Drug Manufacturers - Specialty & Generic

★ Watchlist ⧉ Add to bucket

₹15.23

+1.4% today · 30d -0.33%

as of 2026-09-04

Price · Daily Candles

Detect candlestick pattern

AI narrative is temporarily unavailable for ORTINGLOBE. The deterministic sections below render from live data.

₹ Latest Earnings · Q ending 2026-03-31

REVENUE

₹0 Cr

-24.06% YoY

NET PROFIT

₹0 Cr

OPM

-2.4%

+184.15pp YoY

EPS

₹-0.01

Intrinsic value · DCF: N/A — Company is currently free-cash-flow negative (-4.7% of mktcap). DCF assumes a going concern generating positive cash flow; a meaningful intrinsic value can only be computed once FCF turns positive. Use the Strategy Fit and ML sections instead.

◇ Sector Position

PEERPEROCE %

ORTINGLOBE——

SUNPHARMA37.5721.44

DIVISLAB89.1821.56

ZYDUSLIFE24.6424.22

+ 2 more peers — sign in to view

ML Forward Growth Predictions 🔒

9 ML-predicted forward-growth ranks across sales, EBIT, and FCF.

SCORE / 100

Overall

6-axis composite of the sections below.

Performance STRONG 75

Valuation — —

Growth DECLINING 25

Profitability LOW 5

Technicals WEAK 30

Risk LOW 90

Key Stats

P/B

11.61

52W HIGH

₹21.3

OFF HIGH

-28.5%

MKT CAP

₹12 Cr

◉ Active Signals

MACDBearish-0.0116

RSI(14)Neutral47.23

⧉ Strategy Fit 🔒

See which of ftInvstr's 50+ strategies hold ORTINGLOBE and at what entry.